Cheryl R Blanchard is President, CEO, Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 151,694 shares of ANIK, which is worth approximately $2.6 Million. The most recent transaction as insider was on Mar 11, 2024, when has been sold 27,980 shares (Common Stock) at a price of $25.54 per share, resulting in proceeds of $714,609. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
0% 3M change
32.77% 12M change
Total Value Held $2.6 Million

Cheryl R Blanchard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2024
SELL
Payment of exercise price or tax liability
$714,609 $25.54 p/Share
27,980 Reduced 15.57%
151,694 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
-
64,480 Added 27.95%
166,228 Common Stock
Apr 26 2023
SELL
Payment of exercise price or tax liability
$287,106 $26.34 p/Share
10,900 Reduced 8.71%
114,255 Common Stock
Apr 26 2023
BUY
Exercise of conversion of derivative security
-
24,575 Added 16.41%
125,155 Common Stock
Mar 10 2023
SELL
Payment of exercise price or tax liability
$344,807 $26.1 p/Share
13,211 Reduced 11.61%
100,580 Common Stock
Mar 10 2023
BUY
Exercise of conversion of derivative security
-
30,060 Added 20.9%
113,791 Common Stock
Mar 09 2023
SELL
Payment of exercise price or tax liability
$113,883 $26.91 p/Share
4,232 Reduced 4.81%
83,731 Common Stock
Mar 09 2023
BUY
Exercise of conversion of derivative security
-
14,419 Added 14.08%
87,963 Common Stock
Apr 26 2022
BUY
Exercise of conversion of derivative security
-
24,576 Added 25.23%
72,826 Common Stock
Mar 11 2022
BUY
Open market or private purchase
$207,279 $25.59 p/Share
8,100 Added 11.9%
59,992 Common Stock
Mar 09 2022
BUY
Exercise of conversion of derivative security
-
14,420 Added 21.75%
51,892 Common Stock
Jun 15 2021
BUY
Exercise of conversion of derivative security
$100,000 $33.4 p/Share
2,994 Added 7.4%
37,472 Common Stock
Apr 26 2021
BUY
Exercise of conversion of derivative security
-
24,575 Added 41.62%
34,478 Common Stock

Also insider at

DARE
Dare Bioscience, Inc. Healthcare
VIGL
Vigil Neuroscience, Inc. Healthcare
CRB

Cheryl R Blanchard

President, CEO, Director
Bedford, MA

Track Institutional and Insider Activities on ANIK

Follow Anika Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK